These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 23975747)

  • 1. Simultaneous reversal of risk factors for cardiac death and intensified therapy in long-term survivors of paediatric end-stage renal disease over the last 10 years.
    Vogelzang JL; Heestermans LW; van Stralen KJ; Jager KJ; Groothoff JW
    Nephrol Dial Transplant; 2013 Oct; 28(10):2545-52. PubMed ID: 23975747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trend from cardiovascular to non-cardiovascular late mortality in patients with renal replacement therapy since childhood.
    Vogelzang JL; van Stralen KJ; Jager KJ; Groothoff JW
    Nephrol Dial Transplant; 2013 Aug; 28(8):2082-9. PubMed ID: 23468535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of pay for performance on the control of blood pressure in people with chronic kidney disease stage 3-5.
    Karunaratne K; Stevens P; Irving J; Hobbs H; Kilbride H; Kingston R; Farmer C
    Nephrol Dial Transplant; 2013 Aug; 28(8):2107-16. PubMed ID: 23658247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the incidence of chronic kidney disease Stage 5 requiring renal replacement therapy in the diabetic population of Catalonia.
    Comas J; Arcos E; Castell C; Cases A; Martínez-Castelao A; Doñate T; Esmatjes E
    Nephrol Dial Transplant; 2013 May; 28(5):1191-8. PubMed ID: 23147160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in glomerular filtration rate during pre-dialysis phase and survival on chronic renal replacement therapy.
    Haapio M; Helve J; Kurimo P; Forslund T; Grönhagen-Riska C; Finne P
    Nephrol Dial Transplant; 2012 Mar; 27(3):1157-63. PubMed ID: 21810761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
    Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
    Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of chronic renal failure: results from an unselected, population-based, inception cohort in Sweden.
    Evans M; Fryzek JP; Elinder CG; Cohen SS; McLaughlin JK; Nyrén O; Fored CM
    Am J Kidney Dis; 2005 Nov; 46(5):863-70. PubMed ID: 16253726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival of children with end-stage renal disease.
    McDonald SP; Craig JC;
    N Engl J Med; 2004 Jun; 350(26):2654-62. PubMed ID: 15215481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strict blood-pressure control and progression of renal failure in children.
    ; Wühl E; Trivelli A; Picca S; Litwin M; Peco-Antic A; Zurowska A; Testa S; Jankauskiene A; Emre S; Caldas-Afonso A; Anarat A; Niaudet P; Mir S; Bakkaloglu A; Enke B; Montini G; Wingen AM; Sallay P; Jeck N; Berg U; Caliskan S; Wygoda S; Hohbach-Hohenfellner K; Dusek J; Urasinski T; Arbeiter K; Neuhaus T; Gellermann J; Drozdz D; Fischbach M; Möller K; Wigger M; Peruzzi L; Mehls O; Schaefer F
    N Engl J Med; 2009 Oct; 361(17):1639-50. PubMed ID: 19846849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Predictors of early death during dialysis].
    Caravaca F; Arrobas M; Pizarro JL; Cancho B; Cubero JJ; Espárrago JF; García MC; Sánchez-Casado E
    Nefrologia; 2001; 21(3):274-82. PubMed ID: 11471308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study.
    Tsakiris DJ; Stel VS; Finne P; Fraser E; Heaf J; de Meester J; Schmaldienst S; Dekker F; Verrina E; Jager KJ
    Nephrol Dial Transplant; 2010 Apr; 25(4):1200-6. PubMed ID: 20037169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study.
    Svensson M; Dahle DO; Mjøen G; Weihrauch G; Scharnagl H; Dobnig H; März W; Jardine A; Fellström B; Holdaas H
    Nephrol Dial Transplant; 2012 Jun; 27(6):2571-5. PubMed ID: 22172725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical practice patterns and socio-economic factors may explain geographical variation of end-stage renal disease incidence.
    Couchoud C; Guihenneuc C; Bayer F; Lemaitre V; Brunet P; Stengel B;
    Nephrol Dial Transplant; 2012 Jun; 27(6):2312-22. PubMed ID: 22121236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with kidney disease progression and mortality in a referred CKD population.
    Hoefield RA; Kalra PA; Baker P; Lane B; New JP; O'Donoghue DJ; Foley RN; Middleton RJ
    Am J Kidney Dis; 2010 Dec; 56(6):1072-81. PubMed ID: 20692750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of multidisciplinary care for chronic kidney disease in Taiwan: a 3-year prospective cohort study.
    Chen YR; Yang Y; Wang SC; Chiu PF; Chou WY; Lin CY; Chang JM; Chen TW; Ferng SH; Lin CL
    Nephrol Dial Transplant; 2013 Mar; 28(3):671-82. PubMed ID: 23223224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
    Desideri G; Panichi V; Paoletti S; Grassi D; Bigazzi R; Beati S; Bernabini G; Rosati A; Ferri C; Taddei S; Ghiadoni L;
    Nephrol Dial Transplant; 2011 Sep; 26(9):2983-8. PubMed ID: 21303961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement therapy in infants and children with hepatorenal syndrome awaiting liver transplantation: a case-control study.
    Elizabeth Parsons C; Nelson R; Book LS; Kyle Jensen M
    Liver Transpl; 2014 Dec; 20(12):1468-74. PubMed ID: 25179803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of circulating endothelial microparticles for cardiovascular mortality in end-stage renal failure: a pilot study.
    Amabile N; Guérin AP; Tedgui A; Boulanger CM; London GM
    Nephrol Dial Transplant; 2012 May; 27(5):1873-80. PubMed ID: 22036944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.